Jul 202013
 

Tikal was hot, really really really hot. The room I stayed in didn’t have any air-conditioning, all I had was two little fans. So, I’d have a few beers and read a bit of George Orwell’s 1984 to get me to sleep. This worked to get me to sleep; nothing could keep me asleep. As the sun began to peak up over the jungle, the heat started to climb and I rose out of bed. One morning, with nothing else to do, I set out with my camera gear and got today’s photo of a small boat dock with canoes available for rent tied up to it.

Two canoes tied to a dock on a golden morning in tikal, guatemala

  6 Responses to “Tikal Boat Dock Morning, Guatemala”

  1. Sermorelin and ipamorelin are two peptides that have gained popularity
    in the fields of anti-aging medicine, athletic performance enhancement, and medical
    research because they stimulate the body’s own production of human growth hormone (HGH).
    Both compounds belong to a class called growth hormone releasing hormones (GHRHs) or growth hormone secretagogues.

    While they share a common goal—to increase HGH levels in a natural and safe way—their structures, mechanisms of action, pharmacokinetics, side-effect profiles, and practical applications differ
    significantly. Understanding these differences is essential
    for deciding which peptide might be more suitable for a particular therapeutic
    or performance objective.

    Introduction to Ipamorelin and Sermorelin

    Ipamorelin (also known as GHRP-6) is a pentapeptide that mimics the action of ghrelin,
    a stomach hormone involved in appetite regulation. Its sequence is
    Pro–Trp–Gly–Gln–NH2, and it acts primarily through the growth hormone secretagogue receptor type
    2 (GHS-R2). The peptide’s short chain allows for rapid
    absorption when administered subcutaneously or intramuscularly, leading to a quick rise in circulating HGH levels that
    typically peaks within 30 minutes. Ipamorelin is unique among GHRPs
    because it has minimal impact on the secretion of other pituitary hormones such as prolactin and cortisol.

    Sermorelin (also called sermonyl or Cetrorelix) is a synthetic analogue of growth hormone-releasing hormone (GHRH).
    It consists of a 24-residue peptide that mimics the natural ligand for the
    GHS-R1a receptor. Sermorelin stimulates the pituitary gland to release HGH in a pulsatile fashion, closely resembling physiological secretion patterns.
    Its longer amino acid chain results in a slightly slower onset and a more prolonged
    duration of action compared with ipamorelin. Because sermoneil is designed to be structurally similar
    to native GHRH, it has a low potential for off-target effects.

    Understanding Human Growth Hormone (HGH)

    Human growth hormone is a polypeptide produced by the anterior pituitary gland and plays a
    critical role in growth, metabolism, tissue repair, and overall
    vitality. HGH acts on multiple tissues by binding to the growth hormone
    receptor (GHR), triggering intracellular signaling pathways such
    as JAK2-STAT5, MAPK, and PI3K-Akt. These cascades promote protein synthesis, lipolysis,
    gluconeogenesis, and cell proliferation. In adults, HGH levels decline with age—a phenomenon often referred to as somatopause—leading to reduced muscle mass, increased fat accumulation, decreased bone density, impaired
    cognition, and a slower recovery from injury.

    The therapeutic appeal of stimulating endogenous HGH production lies in the
    fact that the hormone is produced naturally by the body, thereby reducing risks associated with exogenous recombinant HGH injections such as acromegaly, edema, insulin resistance, or
    cartilage overgrowth. Growth hormone secretagogues like ipamorelin and sermoneil offer
    a more physiologic approach: they trigger the pituitary to release HGH in pulses that mimic natural circadian rhythms.

    Ipamorelin vs. Sermorelin: Which is Better for You?

    The decision between ipamorelin and sermoneil depends on several
    key factors, including desired outcome, dosing convenience, side-effect tolerance, cost considerations,
    and the specific clinical or athletic context.

     Mechanism of Action and Hormonal Profile

    – Ipamorelin stimulates GH secretion via ghrelin receptors,
    producing a robust increase in HGH while sparing prolactin and
    cortisol. This selective profile makes it attractive for individuals concerned about potential metabolic side-effects such
    as insulin resistance or mood changes that can accompany broader pituitary
    stimulation.
    – Sermoneil activates GHS-R1a receptors,
    leading to a natural pulsatile release of HGH along with modest increases in other pituitary hormones like prolactin.
    The slight elevation in prolactin may be beneficial for certain therapeutic indications (e.g.,
    breast tissue growth in transgender patients) but can also lead
    to mild water retention or gynecomastia in susceptible
    individuals.

     Onset, Duration, and Dosing Frequency

    – Ipamorelin’s rapid onset means a quick spike in HGH
    that subsides within a few hours. This property is useful for athletes who need a short burst of anabolic
    activity dianabol before and after video training sessions.
    Because the effect is transient, daily injections are often required to
    maintain steady HGH levels.
    – Sermoneil has a slower rise but offers a more sustained release lasting several hours.
    For individuals seeking long-term hormonal balance—such as patients
    with growth hormone deficiency or older adults aiming for gradual rejuvenation—a once-daily
    dose of sermoneil may suffice.

     Side-Effect Profile

    – Both peptides are generally well tolerated, but ipamorelin’s minimal impact on other
    pituitary hormones translates to fewer side-effects like fluid retention, edema, or mood swings.
    Rarely, some users report mild injection site irritation or transient
    nausea.
    – Sermoneil may cause modest water retention due to prolactin stimulation; occasional
    headaches and dizziness have been reported in a small subset of users.

    Because sermoneil more closely mimics physiological secretion, it is considered
    safer for long-term use, though monitoring by a healthcare professional
    remains advisable.

     Cost and Accessibility

    – Ipamorelin is often available at lower wholesale prices due to its shorter peptide chain and simpler
    synthesis. This makes it attractive for athletes or bodybuilders who require frequent dosing but have
    budget constraints.
    – Sermoneil’s longer sequence and more complex manufacturing
    process typically result in a higher cost per dose.
    However, the potential benefit of reduced injection frequency can offset this expense over time.

     Clinical Applications

    – Ipamorelin is frequently used for anti-aging protocols where rapid,
    intermittent HGH release is desired to promote muscle anabolism, fat loss, and
    improved recovery after exercise. It also has a role in treating conditions such as
    sarcopenia or cachexia when administered under medical supervision.
    – Sermoneil is favored in endocrine practice for patients with
    documented growth hormone deficiency, as it encourages
    the pituitary to resume natural HGH production. It is also employed in some
    anti-aging clinics where a more physiologic pattern of secretion is prioritized.

     Regulatory Status and Safety

    – Both peptides are considered prescription-only substances in many jurisdictions.
    In the United States, ipamorelin and sermoneil are classified as investigational
    new drugs (IND) for human use and require an FDA
    waiver or clinical trial approval to distribute legally.
    Off-label usage is common among athletes and bodybuilders but
    may carry legal risks.
    – Importantly, neither peptide has been linked to long-term carcinogenicity in controlled studies,
    but ongoing surveillance of adverse events is essential.

    Practical Considerations for Choosing Between Them

    If you are a professional athlete looking for
    quick anabolic support with minimal hormonal disruption, ipamorelin’s rapid onset and
    low side-effect profile make it an attractive choice. For individuals seeking long-term endocrine balance—particularly those who
    have been diagnosed with growth hormone deficiency or who desire
    a more natural HGH secretion pattern—sermoneil offers a safer, physiologic
    alternative.

    When deciding which peptide to incorporate into a therapy plan, consult with a qualified
    healthcare provider who can assess your hormonal baseline, medical history, and specific goals.
    A comprehensive blood panel—including basal cortisol, prolactin, thyroid function, and IGF-1
    levels—will help determine the most appropriate secretagogue and guide dosing frequency.

    In summary, both ipamorelin and sermoneil provide effective means of stimulating endogenous HGH production,
    but they differ in mechanism, hormonal side-effects, onset and
    duration of action, cost, and suitability for specific therapeutic or performance
    objectives. A thoughtful assessment of your individual needs and a discussion with an experienced
    clinician will help you choose the peptide that best aligns with your goals for health, vitality, and
    athletic excellence.

  2. I don’t think the title of your article matches the content lol. Just kidding, mainly because I had some doubts after reading the article.

  3. the green in the boat almost fluoresces…..

  4. I like the water too.

  5. water looks like liquid gold
    nice shot

 Leave a Reply

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

(required)

(required)